Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Absea (Suzhou) Science And Technology Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being handled by 1 distinct examiner, reflecting a singular point of contact for the company's current prosecution. The filing is located within 1 distinct art unit, which indicates that the company's immediate technical focus is limited to a specific sub-sector of biotechnology.
The busiest examiner identified for this portfolio is BERTOGLIO, VALARIE E, who oversees 1 busiest examiner pending action. This single action constitutes the total volume of pending office actions for the company. With only 1 distinct examiner and 1 distinct art unit involved, the prosecution strategy is highly centralized. Practitioners must tailor their approach to the specific examination patterns of BERTOGLIO, VALARIE E to move the 1 pending office action toward allowance. The narrow focus within 1 distinct art unit suggests that the company is currently prioritizing a specific technical advancement rather than a broad array of diverse filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERTOGLIO, VALARIE E | 1 | 64.1% | +30.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18486336 | METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE | BERTOGLIO, VALARIE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18486336 | METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE | BERTOGLIO, VALARIE E | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18486336 | METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE | BERTOGLIO, VALARIE E | 1632 | §102§112 | Final Rejection | — | Pending | Oct 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAbsea (Suzhou) Science And Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Valarie E Bertoglio has the most, with 1 of Absea (Suzhou) Science And Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
